Triple H ODC Trial
3H-ODC
Determination of the Oxygen Dissociation Curve Under the Conditions of an Avalanche Burial With an Air Pocket
1 other identifier
interventional
30
1 country
1
Brief Summary
In an avalanche burial with an air pocket hypercapnia (and hypoxia) develops within few minutes, hypercapnia increases the rate of cooling and therefore the development of hypothermia. The Triple H Syndrome (Hypoxia, Hypercapnia, Hypothermia) occurs. This specific combination of the three parameters is unique for avalanche burial with an air pocket. Every single parameter has a substantial effect on the hemoglobin-oxygen dissociation curve, but until now no study described the combination of these three parameters. This curve will be measured under these specific conditions in a specifically developed in vitro model, to quantify its shifts and to show if there are combined effects of pCO2 and temperature. The newly developed method will be validated in comparison with an established method. The project will be performed with whole blood, drawn by healthy volunteers, in an experimental setting. The samples will be blinded to the investigator and analyzed in a randomized manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2019
CompletedFirst Posted
Study publicly available on registry
August 1, 2019
CompletedStudy Start
First participant enrolled
August 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2020
CompletedSeptember 9, 2020
September 1, 2020
3 months
July 26, 2019
September 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
amount of p50 in different levels of hypercapnia and hypothermia
amount of p50 in mmHg (p50 = pO2 when oxygen saturation of hemoglobin is 50%)
day 1
Secondary Outcomes (2)
amount of p50 shift due to sex
day 1
amount of inflection point in different levels of hypercapnia and hypothermia
day 1
Interventions
venous blood sampling for oxygen affinity in-vitro test
Eligibility Criteria
You may qualify if:
- years
- fasted situation
- ASA I
- Informed Consent
You may not qualify if:
- any drug abuse
- any drug intake within the last 10 days
- smoking
- known hemoglobinopathy
- relevant illness within last 14 days
- relevant blood loss within last 14 days
- pregnancy or breast-feeding
- participation in any pharmacological study
- exposure to high altitude (\> 3000 m) within last 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General and Surgical Critical Care Medicine, Medical University of Innsbruck
Innsbruck, 6020, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mathias Ströhle, MD
Medical University Innsbruck
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2019
First Posted
August 1, 2019
Study Start
August 26, 2019
Primary Completion
November 30, 2019
Study Completion
February 10, 2020
Last Updated
September 9, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share